News

Phase 3 Trial Enrollment Underway for Parkinson’s Disease Motor Movement Therapy

NeuroDerm has started enrolling Parkinson’s disease (PD) patients in iNDiGO, a Phase 3 clinical trial evaluating the effectiveness of ND0612L, the company’s levodopa/carbidopa (LD/CD) subcutaneous liquid formulation. Levodopa and dopamine agonists, the first line of defense against Parkinson’s disease, are drugs commonly used to improve and control the symptoms of tremor, muscular…

Portland, Oregon Prepares for 2016 World Parkinson’s Congress in September

The nonprofit Parkinson’s Resources of Oregon (PRO) will unveil a series of Parkinson’s Ready training for the Portland Police Department, local hospitals and clinics (Legacy Health Systems), Portland International Airport security services (Transportation Security Administration), and local hotels in downtown Portland. The initiative is included in the organization’s program…

Virtual Reality System Being Tested That Might Detect Parkinson’s Disease

A collaborative effort between two Russian technology institutes may result in a virtual reality system that is able to detect and diagnose such neurodegenerative diseases as Parkinson’s, Alzheimer’s, and multiple sclerosis. According to the Virtual Reality Society, virtual reality systems would allow a healthcare provider to conduct diagnostic assessments without the need for more invasive,…